Literature DB >> 19605872

Cystic fibrosis papers of the year 2008.

Ian M Balfour-Lynn1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19605872      PMCID： PMC2711860          DOI： 10.1258/jrsm.2009.s19007

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  7 in total

1.  Non-invasive ventilation for the treatment of hypercapnic respiratory failure in cystic fibrosis.

Authors:  Peadar G Noone
Journal:  Thorax       Date:  2008-01       Impact factor: 9.139

2.  Reduced lung function in cystic fibrosis: a primary or secondary phenotype?

Authors:  Stephanie D Davis; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2008-07-01       Impact factor: 21.405

3.  Should we stop using intravenous gentamicin in patients with cystic fibrosis?

Authors:  Christopher H Goss
Journal:  Thorax       Date:  2008-06       Impact factor: 9.139

4.  Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.

Authors:  Ronald L Gibson; George Z Retsch-Bogart; Christopher Oermann; Carlos Milla; Joseph Pilewski; Cori Daines; Richard Ahrens; Kevin Leon; Morty Cohen; Sharon McNamara; Tracy L Callahan; Richard Markus; Jane L Burns
Journal:  Pediatr Pulmonol       Date:  2006-07

5.  Survey of acute renal failure in patients with cystic fibrosis in the UK.

Authors:  Carol Bertenshaw; Alan R Watson; Sarah Lewis; Alan Smyth
Journal:  Thorax       Date:  2007-01-18       Impact factor: 9.139

6.  Lung transplantation and survival in children with cystic fibrosis.

Authors:  Theodore G Liou; Frederick R Adler; David R Cox; Barbara C Cahill
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

7.  Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

Authors:  Michael Wilschanski; Yaacov Yahav; Yasmin Yaacov; Hannah Blau; Lea Bentur; Joseph Rivlin; Micha Aviram; Tali Bdolah-Abram; Zsuzsa Bebok; Liat Shushi; Batsheva Kerem; Eitan Kerem
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.